Centers of Cancer Nanotechnology Excellence (CCNEs)(U54) | Apply Online

Opportunity Summary:

The Centers of Cancer Nanotechnology Excellence (CCNEs) (U54) opportunity, issued by the National Cancer Institute (NCI) under the NIH, funds the creation of a coordinated set of research centers that collectively form the backbone of the NCI Alliance for Nanotechnology in Cancer. The basic idea is to build a national, collaborative network where cutting-edge nanotechnology work is directly connected to real cancer needs, with an emphasis on moving promising concepts toward practical, clinically meaningful applications. These CCNEs are intended to operate as major hubs within the broader Alliance program, alongside smaller related efforts such as Cancer Nanotechnology Platform Projects (CNPPs) and training programs, so the overall ecosystem includes both large center-scale teams and supporting projects that help accelerate progress and workforce development.

A central focus of the program is true multidisciplinary, team-based research. NCI is specifically looking to link physical scientists, engineers, and nanoscale technologists with cancer biologists and clinical oncologists who understand the realities of diagnosis, prevention, and treatment. The expectation is not just that these groups collaborate in name, but that they form integrated teams capable of identifying genuinely innovative research directions and then demonstrating the translational potential of the resulting technologies. In practical terms, the program is designed to reduce the gap between invention and oncology impact by ensuring that technology development is guided early by biological understanding, clinical constraints, and realistic pathways to use in patients or clinically relevant settings.

In terms of what the funded centers are expected to work on, the FOA highlights nanotechnology-based techniques and tools that can be applied across several parts of the cancer pipeline. This includes early disease diagnosis, such as in vitro assays and devices that could detect cancer or cancer-related signals with improved sensitivity, specificity, or speed. It also includes in vivo imaging technologies, where nanoscale agents or systems can enhance imaging contrast, targeting, multiplexing, or functional readouts in living systems. Another priority area is multifunctional therapeutic solutions, which often means nanoscale approaches that can combine targeting, drug delivery, controlled release, imaging, and/or therapy in a coordinated way. The announcement also points to cancer prevention and control, signaling interest in tools that can reduce risk, improve monitoring, or support interventions beyond traditional treatment, provided the nanotechnology angle is central and the oncology relevance is clear.

Mechanistically, this is a cooperative agreement (U54), which generally implies substantial scientific and programmatic involvement by the funding agency compared to a standard research project grant. While the text provided does not spell out the specific collaboration requirements, the cooperative agreement structure and the network concept strongly indicate that awardees are expected to participate actively in Alliance-wide coordination, share advances, and contribute to collective goals rather than operating as isolated centers. The overarching goal, stated plainly, is to speed up nanotechnology discoveries and convert them into cancer-relevant applications with potential clinical utility, emphasizing rapid advancement and meaningful translation rather than purely exploratory nanoscale science.

From an administrative standpoint, the FOA is identified as RFA-CA-09-012, posted May 28, 2009, with an original and current closing date of October 14, 2009, and an archive date of November 14, 2009. There is no cost sharing or matching requirement listed. The award ceiling is $3,200,000, indicating support at a scale consistent with center-level infrastructure and team science. The activity categories and CFDA listings span the breadth of cancer research, including cause and prevention (93.393), detection and diagnosis (93.394), treatment (93.395), and control (93.399), which aligns with the wide range of applications NCI wants nanotechnology to influence.

Eligibility is broad and includes many common applicant types such as public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (with and without 501(c)(3) status), small businesses, and state, county, and city or township governments. The announcement also allows additional eligible applicants such as certain federal government agencies, regional organizations, and U.S. territories or possessions, suggesting the program is open to a wide set of organizations capable of building the kind of interdisciplinary teams and resources needed for a CCNE. The full announcement is available through the NIH grants guide at the provided link, and NIH’s Office of Extramural Research (OER) webmaster contact is included for access or linking issues.

Browse more business programs for Technology Service Providers, Nanotechnology Companies

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Cancer Nanotechnology Platform Partnerships (U01)

Previous opportunity: BLM WY Sublette County Conservation District Rangeland Management Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 09 012

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 09 012) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 09 012", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.